Back to Journals » Drug Design, Development and Therapy » Volume 9

A phase I/II study of biweekly capecitabine and irinotecan plus bevacizumab as second-line chemotherapy in patients with metastatic colorectal cancer

Total article views   HTML views PDF downloads Totals
12,441 Dovepress* 11,189+ 1,736 12,925
PubMed Central* 1,252 487 1,739
Totals 12,441 2,223 14,664
*Since 16 March 2015
+Since July 2016

View citations on PubMed Central and Google Scholar